Study type: In vivo/preclinical · Verification: Citation verified
587 – Pentadecapeptide Bpc 157 Therapy in Bile Duct Ligated (BDL) Rats. in the Liver Tissue, Bpc 157 Counteracts the Increased Nos3 Expression, Il-6, TNF-Α, Il-1Β Levels, and Ki-67 Presentation
Gastroenterology · 2019
Study scale: Not reported in the declared source.
Bibliographic details only: Open source record
Product or molecular entity relationships
- BPC-157: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
No public summary
No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.
Limitations and uncertainty
Not reported in the declared source.
Citation verified. The DOI shown was confirmed at Crossref on 2026-08-20, and its study type matched the catalog’s source record. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.